Kwang Dong Pharmaceutical Co., Ltd. (KRX:009290)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,080.00
+100.00 (1.67%)
At close: Dec 5, 2025

Kwang Dong Pharmaceutical Revenue

Kwang Dong Pharmaceutical had revenue of 444.52B KRW in the quarter ending September 30, 2025, with 4.69% growth. This brings the company's revenue in the last twelve months to 1.64T, up 0.25% year-over-year. In the year 2024, Kwang Dong Pharmaceutical had annual revenue of 1.64T with 8.34% growth.

Revenue (ttm)
1,638.24B
Revenue Growth
+0.25%
P/S Ratio
0.15
Revenue / Employee
1.60B
Employees
1,021
Market Cap
238.83B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20241,640.72B126.26B8.34%
Dec 31, 20231,514.45B82.91B5.79%
Dec 31, 20221,431.55B93.36B6.98%
Dec 31, 20211,338.18B94.41B7.59%
Dec 31, 20201,243.77B5.51B0.45%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
KT&G Corporation 6,422.32B
Samyang Foods 2,192.96B
APR Co., Ltd. 1,223.92B
Amorepacific 4,181.14B
LG H&H 6,492.62B
ORION 3,269.67B
CJ Cheiljedang 29.38T
Dong Suh Companies 527.45B
Revenue Rankings